Yvesna Blaise

FDA investigator

Appears on 8 documents from 2016 to 2020, mostly at sites in New Jersey. Most often cites testing and release for distribution (21 CFR 211.165).

8
Documents on file
3.1
Observations per 483
2016
First seen
2020
Most recent

What they cite most

From 25 observations

Activity by year

2016: 1, 2017: 1, 2018: 2, 2019: 3, 2020: 1

Where

New Jersey 6 · New York 1 · Pennsylvania 1

Is Yvesna Blaise coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

8 documents, newest first
FirmOpen
483 Pro-Blending LLCFeb 5, 2020 · Linden, New Jersey
483 AIRGAS USA, LLCMay 30, 2019 · Elmira, New York
483 KVK-Tech, IncApr 16, 2019 · Newtown, Pennsylvania
483 QUAGEN PHARMACEUTICALS LLCMar 15, 2019 · West Caldwell, New Jersey
483 ImClone Systems LLCMar 9, 2018 · Branchburg, New Jersey
483 Sunrise Pharmaceutical, IncJan 18, 2018 · RAHWAY, New Jersey
483 Actavis Elizabeth LLCFeb 15, 2017 · Elizabeth, New Jersey

About this profile

What does Yvesna Blaise inspect?

Yvesna Blaise appears on 8 documents on file covering 8 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.165 (testing and release for distribution), followed by 21 CFR 211.160 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Yvesna Blaise is dated Feb 5, 2020.